Synthesis of carbon-14, carbon-13 and deuterium labeled forms of thioacetamide and thioacetamide S-oxide

被引:6
|
作者
Sarma, Diganta [1 ]
Hanzlik, Robert P. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
基金
美国国家卫生研究院;
关键词
acetate; thioacetamide; thioacetamide S-oxide; deuterium exchange; pyrolysis; REACTIVE METABOLITES; LIVER-INJURY; RAT; THIOBENZAMIDE;
D O I
10.1002/jlcr.1933
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Thioacetamide (TA) is a model hepatotoxin that undergoes metabolic activation via two successive S-oxidations. The ultimate toxic metabolite thioacetamide S,S-dioxide, or its tautomer acetimidoyl sulfinic acid CH3C(NH)SO2H, then acylates lysine side chains on cellular proteins leading to cellular dysfunction or death. To identify individual target proteins, quantitate the extent of their modification and elucidate the structural details of their modification, we required both radio-labeled and stable-labeled forms of TA and its intermediate metabolite thioacetamide S-oxide (TASO). The latter is stable when purified but can be difficult to isolate. Considering currently available isotopic precursors, we devised and report here methods for the synthesis and isolation of TA and TASO labeled with C-14, C-13, and/or deuterium. The methods are straightforward, utilize readily available precursors, and are amenable to small scale. Copyright (c) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:795 / 798
页数:4
相关论文
共 50 条
  • [41] A potent IκB kinase-β inhibitor labeled with carbon-14 and deuterium
    Latli, Bachir
    Eriksson, Magnus
    Hrapchak, Matt
    Busacca, Carl A.
    Senanayake, Chris H.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (08): : 300 - 304
  • [42] Synthesis of carbon-14 labeled (±) 15-deoxyspergualin trihydrochloride
    Bristol-Myers Squibb, Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, United States
    Journal of Labelled Compounds and Radiopharmaceuticals, 1995, 36 (11): : 1097 - 1103
  • [43] Synthesis of Stable Isotope, Tritiated, and Carbon-14 Labeled Balcinrenone
    Bergare, Jonas
    Bailey, Christopher
    Sorensen, Henrik
    Gronberg, Gunnar
    Broberg, Karl
    Berglund, Monica
    Grecu, Tudor
    Sanchez, Carolina
    Emtenas, Hans
    Bragg, Ryan A.
    Elmore, Charles S.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2024, 67 (04): : 145 - 153
  • [44] Synthesis of imatinib, a tyrosine kinase inhibitor, labeled with carbon-14
    Kang, Julie
    Lee, Jun Young
    Park, Jeong-Hoon
    Chang, Dong-Jo
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2020, 63 (04): : 174 - 182
  • [45] Synthesis of carbon-14 labeled antioxidant pyrrolopyrimidine compounds.
    Stolle, WT
    Hsi, RSP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 216 - MEDI
  • [46] SYNTHESIS FOR CARBON-14 LABELED DL-GLUTAMIC ACID
    SPEER, RJ
    ROBERTS, A
    MALONEY, M
    MAHLER, HR
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1952, 74 (09) : 2444 - 2444
  • [47] Potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 labeled with carbon-13 and carbon-14 (vol 60, pg 420, 2017)
    Latli, Bachir
    Hrapchak, Matt
    Savoie, Jolaine
    Zhang, Yongda
    Busacca, Carl A.
    Senanayake, Chris H.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2018, 61 (02): : 118 - 118
  • [48] SYNTHESIS OF SEVERAL CARBON-14 LABELED DL-ALANINES
    OSTWALD, R
    ADAMS, PT
    TOLBERT, BM
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1952, 74 (09) : 2425 - 2427
  • [49] An efficient for synthesis of bexagliflozin and its carbon-13 labeled analogue
    Xu, Ge
    Xu, Baihua
    Song, Yanli
    Sun, Xun
    TETRAHEDRON LETTERS, 2016, 57 (42) : 4684 - 4687
  • [50] A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium
    Latli, Bachir
    Hrapchak, Matt
    Gao, Joe J.
    Busacca, Carl A.
    Senanayake, Chris H.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 (09): : 390 - 394